The influence of a synthetic growth hormone‐releasing hormone analogue G11 and opioid peptide biphalin on selected fibroblasts parameters relevant to wound healing

Abstract

The treatment of hard‐to‐heal chronic wounds is still a major medical problem and an economic and social burden. In this work, we examine the proregenerative potential of two peptides, G11 (a trypsin‐resistant analogue of growth hormone‐releasing hormone [GHRH]) and biphalin (opioid peptide), and their combination in vitro on human fibroblasts (BJ). G11, biphalin and their combination exhibited no toxicity against BJ cells. On the contrary, these treatments significantly stimulated proliferation and migration of fibroblasts. Under inflammatory conditions (LPS‐induced BJ cells), we noticed that the tested peptides decreased the levels of cyclooxygenase‐2 (COX‐2), inducible nitric oxide synthase (iNOS) and interleukin 1β (IL‐1β). This was correlated with diminished phosphorylation levels of p38 kinase, but not those of ERK1/2. We found also that G11, biphalin and their combination activated the ERK1/2 signalling pathway, which has been previously implicated in promigratory activity of some regeneration enhancers, including opioids or GHRH analogues. Potential application of their combination requires further work, in particular in vivo experiments, in which the organism‐level relevance of the discussed cell‐level effects would be proven and, additionally, analgesic action of the opioid ingredient could be quantified.